Quarterly report · Q3
2533.TEDINET S100S4PL
Period2023-01-01 → 2023-09-30
Filed2023-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥62.1bn | 2023-01-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥81.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥58.0bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥2.5bn | 2023-01-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | −¥869m | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.6bn | 2023-01-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥645m | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥799m | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.6bn | 2023-01-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥909m | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.1bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.3bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.4bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.0bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥1.5bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥54.3bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥55.5bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥52.5bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥35.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥21.0bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥19.6bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.3bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥921m | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥899m | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥35.37 | 2023-01-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.85 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.22 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.73 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.21 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 37.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-09-30 | ¥62m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-09-30 | ¥62m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-09-30 | ¥7m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-09-30 | −¥14m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-09-30 | −¥14m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥359m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥57.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥57.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥14m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥946m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥946m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥490m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥6m |
| —segment total | revenue | 2023-01-01 → 2023-09-30 | ¥62.1bn |
| —segment total | revenue external | 2023-01-01 → 2023-09-30 | ¥62.0bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥14m |
| —segment total | segment profit | 2023-01-01 → 2023-09-30 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | ¥11m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥2m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥381m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥1.1bn |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥151m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥273m |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | −¥880m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 420
| Item | Context | Value | Unit |
|---|---|---|---|
| Rent income noi | Prior1YTDDuration | 50000000 | JPY |
| Rent income noi | CurrentYTDDuration | 46000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 45000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 41000000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 35000000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 34000000 | JPY |
| Non operating income | Prior1YTDDuration | 156000000 | JPY |
| Non operating income | CurrentYTDDuration | 185000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 53000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 69000000 | JPY |
| Cost during the suspension of plant operation | Prior1YTDDuration | 19000000 | JPY |
| Cost during the suspension of plant operation | CurrentYTDDuration | 18000000 | JPY |
| Miscellaneous loss noe | Prior1YTDDuration | 14000000 | JPY |
| Miscellaneous loss noe | CurrentYTDDuration | 12000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 87000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 100000000 | JPY |
| Ordinary income | Prior1YTDDuration | -799000000 | JPY |
| Ordinary income | CurrentYTDDuration | 2614000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | - | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 14000000 | JPY |
| Other ei | Prior1YTDDuration | - | JPY |
| Other ei | CurrentYTDDuration | 0 | JPY |
| Extraordinary income | Prior1YTDDuration | - | JPY |
| Extraordinary income | CurrentYTDDuration | 14000000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 22000000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 7000000 | JPY |
| Impairment loss el | Prior1YTDDuration | - | JPY |
| Impairment loss el | CurrentYTDDuration | 9000000 | JPY |
| A recall related loss el | Prior1YTDDuration | 86000000 | JPY |
| A recall related loss el | CurrentYTDDuration | - | JPY |
| Loss on sales of stocks of subsidiaries and affiliates el | Prior1YTDDuration | - | JPY |
| Loss on sales of stocks of subsidiaries and affiliates el | CurrentYTDDuration | 46000000 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | - | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | 10000000 | JPY |
| Other el | Prior1YTDDuration | 0 | JPY |
| Other el | CurrentYTDDuration | 1000000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 109000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 75000000 | JPY |
| Income before income taxes | Prior1YTDDuration | -909000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 2554000000 | JPY |
| Income taxes | Prior1YTDDuration | 591000000 | JPY |
| Income taxes | CurrentYTDDuration | 504000000 | JPY |
| Profit loss | Prior1YTDDuration | -1500000000 | JPY |
| Profit loss | CurrentYTDDuration | 2049000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | -149000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | -8000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | -1351000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 2058000000 | JPY |
| Profit loss | Prior1YTDDuration | -1500000000 | JPY |
| Profit loss | CurrentYTDDuration | 2049000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |